Benjamin Edwards Inc’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.17M Buy
9,136
+1,435
+19% +$298K 0.02% 549
2026
Q1
$1.63M Buy
7,701
+1,492
+24% +$321K 0.02% 606
2025
Q4
$1.28M Buy
6,209
+541
+10% +$102K 0.01% 630
2025
Q3
$890K Buy
5,668
+1,581
+39% +$244K 0.01% 733
2025
Q2
$687K Sell
4,087
-104
-2% -$15.4K 0.01% 747
2025
Q1
$577K Sell
4,191
-374
-8% -$47.7K 0.01% 740
2024
Q4
$540K Sell
4,565
-65
-1% -$7.59K 0.01% 797
2024
Q3
$512K Buy
4,630
+4,117
+803% +$430K 0.01% 786
2024
Q2
$50K Buy
513
+14
+3% +$1.43K 0.01% 498
2024
Q1
$56K Buy
499
+143
+40% +$15.4K 0.01% 471
2023
Q4
$36K Hold
356
0.01% 498
2023
Q3
$31K Hold
356
0.01% 499
2023
Q2
$34K Hold
356
0.01% 491
2023
Q1
$27K Buy
+356
New +$26.9K 0.01% 514

Other funds holding CAH

Benjamin Edwards Inc's CAH Position: Q2 2026 in Review

Benjamin Edwards Inc increased its Cardinal Health (CAH) stake by 19% in Q2 2026, buying an estimated $298K and bringing the position to 9,136 shares worth $2.17M. The position accounts for 0.02% of the portfolio, ranked #549.

Benjamin Edwards Inc first reported a position in CAH in Q1 2023 and has held it in 14 quarters since. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Benjamin Edwards Inc held 9,136 shares of Cardinal Health worth $2.17M as of Q2 2026.
  • Benjamin Edwards Inc bought 1,435 Cardinal Health shares in Q2 2026, an estimated $298K.
  • Cardinal Health made up 0.02% of Benjamin Edwards Inc's portfolio in Q2 2026, its #549 holding.
  • Benjamin Edwards Inc first reported a position in Cardinal Health in Q1 2023 and has held it in 14 quarters since.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Benjamin Edwards Inc's 13F filing for Q2 2026, filed 24 Jul 2026.